Overview An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKD Status: Terminated Trial end date: 2015-07-01 Target enrollment: Participant gender: Summary FMX-8 is a new type of drug being tested for the treatment of anemia in chronic illnesses. Phase: Early Phase 1 Details Lead Sponsor: FerruMax Pharmaceuticals, Inc.